Edition:
United States

Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

34.98USD
4:02pm EDT
Change (% chg)

$-0.76 (-2.13%)
Prev Close
$35.74
Open
$35.74
Day's High
$36.30
Day's Low
$34.84
Volume
98,949
Avg. Vol
99,341
52-wk High
$44.26
52-wk Low
$16.51

Chart for

About

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The Company's glutamate platform includes three clinical-stage product candidates being... (more)

Overall

Beta: --
Market Cap(Mil.): $1,455.04
Shares Outstanding(Mil.): 40.13
Dividend: --
Yield (%): --

Financials

BRIEF-Biohaven Pharma Qtrly Loss Per Share $2.32

May 15 Biohaven Pharmaceutical Holding Company Ltd:

May 15 2018

BRIEF-Biohaven Initiates Expanded Access Program For Sublingual BHV-0223

May 9 Biohaven Pharmaceutical Holding Company Ltd:

May 09 2018

Earnings vs. Estimates